Michael Boretti

Health Technology

Consumer Services

Profile

Michael Boretti worked as Vice President of Corporate Development at AVEO Pharmaceuticals, Inc. He then worked as Vice President of Business Development at Epizyme, Inc. from 2016 to 2019.
Boretti received his undergraduate degree from the University of Virginia and his doctorate from the University of Pennsylvania.

Former positions of Michael Boretti

Companies	Position	End
EPIZYME, INC.	Corporate Officer/Principal	01/04/2019
AVEO PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

See the detail of Michael Boretti's experience

Training of Michael Boretti

University of Virginia	Undergraduate Degree
University of Pennsylvania	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Boretti's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
AVEO Pharmaceuticals, Inc. AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.	Health Technology
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology